# Effect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI)

> **NCT01129622** · PHASE2 · COMPLETED · sponsor: **Mount Sinai Hospital, Canada** · enrollment: 16 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** letrozole

## Key facts

- **NCT ID:** NCT01129622
- **Lead sponsor:** Mount Sinai Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-09
- **Final completion:** 2010-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01129622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01129622, "Effect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01129622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*